Cagrilintide 10MG

Cagrilintide is a long-acting synthetic amylin analogue developed to investigate metabolic regulation and appetite signaling pathways. Amylin is a naturally occurring peptide hormone co-secreted with insulin by pancreatic beta cells and plays an important role in regulating satiety, gastric emptying, glucagon secretion, and post-meal energy balance.

Due to its enhanced stability and prolonged duration of action, Cagrilintide has become one of the most promising investigational compounds in modern metabolic and obesity research. Researchers are particularly interested in its potential influence on appetite control, caloric intake, body weight regulation, and overall metabolic function.

Unlike GLP-1 receptor agonists, Cagrilintide primarily targets amylin receptors, offering a distinct mechanism of action. It is frequently studied both as a standalone compound and in combination with GLP-1 receptor agonists such as Semaglutide to evaluate complementary metabolic effects.

Key Research Areas

• Amylin receptor signaling
• Appetite regulation and satiety research
• Body weight management studies
• Energy balance investigations
• Gastric emptying research
• Metabolic regulation pathways
• Obesity and metabolic syndrome research
• Combination peptide therapy studies

Product Specifications

• Peptide: Cagrilintide
• Strength: 10mg
• Format: Lyophilized powder
• Classification: Long-acting amylin analogue
• Grade: Research-use peptide
• Purity: High-purity laboratory standard
• Storage: Store refrigerated at 2°C–8°C before reconstitution
• Intended Use: Scientific and laboratory research only

Why Researchers Study Cagrilintide

Cagrilintide has gained significant attention because it represents a new generation of metabolic research compounds targeting the amylin receptor pathway. Researchers investigate its potential role in enhancing satiety, reducing energy intake, and supporting long-term metabolic regulation through mechanisms distinct from GLP-1 receptor agonists.

The peptide is also widely studied in combination with GLP-1-based compounds to better understand potential synergistic effects on appetite regulation, body composition, and metabolic health. This complementary approach has made Cagrilintide one of the most promising investigational peptides in obesity and longevity research.

Important Notice

This product is intended strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Cagrilintide is an investigational research peptide and has not been approved for therapeutic or pharmaceutical applications. Keep out of reach of children.